Laboratory standards and guidelines for population-based cystic fibrosis carrier screening
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“To date, however, preconception carrier testing has been recommended in the United States only for five of these: fragile × syndrome (OMIM #300624) in selected individuals; cystic fibrosis (OMIM #219700) in Caucasians; and TSD, Canavan disease (OMIM #271900), and familial dysautonomia (OMIM #223900) in individuals of Ashkenazi descent (9–13).”
From Carrier testing for severe childhood recessive diseases by next-generation sequencing (2011) · cites this paper as [12]
Citations
Cites
Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNA
Riordan, J. R., Rommens, J. M., Kerem, B.-S., Alon, N., Rozmahel, R., Grzelczak, Z., Zielenski, J., Lok, S., Plavsic, N., Chou, J.-L., et al. (1989) · Science · doi:10.1126/science.2475911 · Cited by 7,418
Identification of the Cystic Fibrosis Gene: Genetic Analysis
Kerem, B.-S., Rommens, J. M., Buchanan, J. A., Markiewicz, D., Cox, T. K., Chakravarti, A., Buchwald, M., & Tsui, L.-C. (1989) · Science · doi:10.1126/science.2570460 · Cited by 4,142 · cited 1×
“sequential); (3) criteria for and selection of the standard mutation testing panel; (4) potential value and use of an extended testing panel with additional mutations; (5) whether to test for mutations and variants associated with mild or nonclassical phenotypes (such as congenital bilateral absence of the vas deferen…”
BackgroundIdentification of the Cystic Fibrosis Gene: Chromosome Walking and Jumping
Rommens, J. M., Iannuzzi, M. C., Kerem, B.-S., Drumm, M. L., Melmer, G., Dean, M., Rozmahel, R., Cole, J. L., Kennedy, D., Hidaka, N., et al. (1989) · Science · doi:10.1126/science.2772657 · Cited by 3,253
Mutations in the Cystic Fibrosis Gene in Patients with Congenital Absence of the Vas Deferens
Chillón, M., Casals, T., Mercier, B., Bassas, L., Lissens, W., Silber, S., Romey, M.-C., Ruiz-Romero, J., Verlingue, C., Claustres, M., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506013322204 · Cited by 952
Congenital bilateral absence of the vas deferens. A primarily genital form of cystic fibrosis
Anguiano, A. (1992) · JAMA · doi:10.1001/jama.267.13.1794 · Cited by 498
A mutation in CFTR produces different phenotypes depending on chromosomal background
Kiesewetter, S., Macek, M., Davis, C., Curristin, S. M., Chu, C.-S., Graham, C., Shrimpton, A. E., Cashman, S. M., Tsui, L.-C., Mickle, J., et al. (1993) · Nature Genetics · doi:10.1038/ng1193-274 · Cited by 441
Self-citationPopulation variation of common cystic fibrosis mutations
The Cystic Fibrosis Genetic Analysis Consortium (1994) · Human Mutation · doi:10.1002/humu.1380040302 · Cited by 309
Geographic distribution and regional origin of 272 cystic fibrosis mutations in European populations
Estivill, X., Bancells, C., Ramos, C., & Biomed CF Mutation Analysis Consortium (1997) · Human Mutation · doi:10.1002/(sici)1098-1004(1997)10:2<135::aid-humu6>3.0.co;2-j · Cited by 295
Kaback, M. (1993) · JAMA · doi:10.1001/jama.1993.03510190063028 · Cited by 258
Distinct spectrum of CFTR gene mutations in congenital absence of vas deferens
Dörk, T., Dworniczak, B., Aulehla-Scholz, C., Wieczorek, D., Böhm, I., Mayerova, A., Seydewitz, H. H., Nieschlag, E., Meschede, D., Horst, J., et al. (1997) · Human Genetics · doi:10.1007/s004390050518 · Cited by 254
Cited by
Drummond, T. G., Hill, M. G., & Barton, J. K. (2003) · Nature Biotechnology · doi:10.1038/nbt873 · Cited by 2,214
Bobadilla, J. L., Macek, M., Fine, J. P., & Farrell, P. M. (2002) · Human Mutation · doi:10.1002/humu.10041 · Cited by 1,032
“Indeed, the exhaustive survey and analyses we performed can serve the need for data allowing determination of an appropriate mutation panel [Grody et al., 2001] that could be used in regional CF neonatal screening programs.”
BackgroundMethodHigh Incidence of Later-Onset Fabry Disease Revealed by Newborn Screening*
Spada, M., Pagliardini, S., Yasuda, M., Tukel, T., Thiagarajan, G., Sakuraba, H., Ponzone, A., & Desnick, R. J. (2006) · The American Journal of Human Genetics · doi:10.1086/504601 · Cited by 1,008
Self-citationThe future of cystic fibrosis care: a global perspective
Bell, S. C., Mall, M. A., Gutierrez, H., Macek, M., Madge, S., Davies, J. C., Burgel, P.-R., Tullis, E., Castaños, C., Castellani, C., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(19)30337-6 · Cited by 974
Cystic fibrosis genetics: from molecular understanding to clinical application
Cutting, G. R. (2015) · Nature Reviews Genetics · doi:10.1038/nrg3849 · Cited by 965
Self-citation
Metadata
- Authors
- Grody, W. W., Cutting, G. R., Klinger, K. W., Richards, C. S., Watson, M. S., & Desnick, R. J.
- Affiliations
- University of California, Los Angeles (US)
- Johns Hopkins University (US)
- Genome Canada (CA)
- Baylor College of Medicine (US)
- American College of Medical Genetics (US)
- Icahn School of Medicine at Mount Sinai (US)
- Venue
- Genetics in Medicine
- Publisher
- Elsevier BV
- Published
- 2001-03
- Volume
- 3
- Issue
- 2
- Pages
- 149-154
- ISSN
- 1098-3600 (ISSN-L)
- OpenAlex
- W2158452114
- Cited by
- 456
- References
- 26
- Citations by year
- 2026: 5 · 2025: 4 · 2024: 10 · 2023: 10 · 2022: 8 · 2021: 11 · 2020: 11 · 2019: 11 · 2018: 15 · 2017: 15 · 2016: 14 · 2015: 17 · 2014: 13 · 2013: 15 · 2012: 17
- FWCI
- 32.79
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 7629 d)
- Locations
- Genetics in Medicine (publishedVersion)
- PubMed (publishedVersion)
- DigitalGeorgetown (Georgetown University Library) (submittedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Screening and Diagnostics
- Keywords
- cystic fibrosis, carrier screening, mass screening, genetic testing, CFTR mutations, prenatal screening
- MeSH terms
- Alleles, Codon, Cystic Fibrosis, Ethics, Medical, Female, Genetic Counseling, Genetic Testing, Heterozygote, Homozygote, Humans, Male, Mutation, Quality Control, Vas Deferens
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Laboratory standards and guidelines for population-based cystic fibrosis carrier screening. https://app.cochat.ai/papers/10.1097/00125817-200103000-00010
- The paper
- Grody, W. W., Cutting, G. R., Klinger, K. W., Richards, C. S., Watson, M. S., & Desnick, R. J. (2001). Laboratory standards and guidelines for population-based cystic fibrosis carrier screening. Genetics in Medicine. https://doi.org/10.1097/00125817-200103000-00010
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.